EVALUATION OF THE IMMUNOADJUVANT POTENTIAL OF RECOMBINANT TRIATOMA VIRUS PROTEINS IN THE CONTEXT OF VISCERAL LEISHMANIASISVisceral leishmaniasis; Leishmania infantum; Triatoma virus; Vaccine adjuvants; Humoral immune response.
Visceral leishmaniasis (VL) is a neglected tropical disease whose treatment presents limitations related to toxicity and parasite resistance. Given the absence of licensed human vaccines, the investigation of novel components with immunoadjuvant potential represents a promising strategy. This study aimed to evaluate the immunoadjuvant potential of the recombinant VP1, VP2, and VP3 proteins from Triatoma virus, associated with the total extract of L. infantum promastigotes, in comparison with conventional adjuvants. The proteins were expressed in Escherichia coli BL21 and purified. BALB/c mice were allocated into five experimental groups: PBS (negative control), a group immunized exclusively with the total extract of L. infantum promastigotes, and the Alum, AIF, and VP mix groups, in which the same antigen was administered in association with the respective components. The humoral immune response was evaluated by indirect ELISA for total IgG and the IgG1, IgG2a, IgG2b, and IgG3 subclasses. Additionally, an indirect immunofluorescence assay was performed using sera from the immunized animals. A pilot experimental infection study was also conducted, including parasitological evaluation. The results demonstrated higher total IgG reactivity in the immunized groups compared with the negative control. On day 75, the Alum, AIF, and VP mix groups exhibited significantly higher reactivity than the group immunized exclusively with the total extract of L. infantum promastigotes. The VP mix group showed higher IgG2a reactivity than the Alum and AIF groups. In the pilot study, viable parasites were recovered from blood cultures of infected animals but not from splenic cultures. Overall, the findings suggest potential immunoadjuvant activity of the VP1, VP2, and VP3 proteins, although further studies are needed to evaluate cellular immune responses and the protective efficacy of immunization.